scholarly journals Cytokine release syndrome and immune-related pneumonitis associated with tumor progression in a pulmonary pleomorphic carcinoma treated with nivolumab plus ipilimumab treatment: A case report

Author(s):  
Kei Kunimasa ◽  
Takako Inoue ◽  
Katsunori Matsueda ◽  
Takahisa Kawamura ◽  
Motohiro Tamiya ◽  
...  
2021 ◽  
Vol 9 (7) ◽  
Author(s):  
Masoud Etemadifar ◽  
Mehri Salari ◽  
Mahdieh Saeri ◽  
Amirhossein Akhavan Sigari ◽  
Sara Ebrahimi Pelarti

Author(s):  
Masoud Etemadifar ◽  
Mehri Salari ◽  
Mahdieh Saeri ◽  
Amirhossein Akhavan Sigari ◽  
Sara Ebrahimi

Rituximab use in multiple sclerosis has been promising. Cytokine release syndrome (CRS) is a common side effect of rituximab in patients with lymphoma. We report a case of a 44-year-old man with a history of relapsing-remitting multiple sclerosis, who presented with signs and symptoms consistent with CRS after rituximab initiation.


Sign in / Sign up

Export Citation Format

Share Document